scalability

Revolutionizing mRNA Manufacturing: How Automation Solves Challenges

June 24, 2024

BIOT

🔍 Addressing mRNA Manufacturing's Biggest Challenges Using Automation. 💪 Automation improves efficiency, scalability, and response time. 🤖⚡️🌍 It also enhances data management and regulatory compliance. 🔐🏭✨

Process development

Revolutionary iPSCs: The Future of Advanced Therapies

June 7, 2024

BIOT

📰 iPSCs: The Holy Grail of Advanced Therapies! 🧬 Scalability, cost-effectiveness, and super-donors are the keys to success. 💰 CCRM leads the way!

Process development

Revolutionizing Cell Therapy Manufacturing: Faster & Safer

May 10, 2024

BIOT

🔎 This article explores the challenges in cell therapy manufacturing and the urgency for faster processes. It discusses closed-process systems, bioreactors, and rapid testing methods to improve efficiency. It emphasizes the significance of streamlined manufacturing and quality control testing for faster treatment delivery. The need for a common manufacturing platform and scalability in cell therapy production is also addressed.

Companies

Revolutionary Cell-Therapy Tech: Scalability Made Simple

March 12, 2024

BIOT

🔍 MFX is revolutionizing cell therapy manufacturing with its scalable Cyto Engine Stack, securing funding for a 2025 release. 🧪📈💰🔬

Process development

Revolutionizing Biomanufacturing: Faster Cheaper and More Efficient

March 1, 2024

BIOT

🧪 Quick production of therapeutics and vaccines using a disease-agnostic platform approach. 📊 Improved mRNA yields in just two hours. 🖥️ Real-time process monitoring and control. 💉 Billions of vaccine doses produced using a platform process. 🧫 Efficient and cost-effective allogeneic cell therapies. 🌐 Scalable, monitored, and controlled manufacturing of advanced therapies and vaccines. 💡 Future perspective: reducing costs and manufacturing risk with platform-based iPSC production.